Molecular diagnostics firm Atonarp secures £26.8m in Series C funding
Atonarp will use funding for its product prototyping and commercialisation in 2020 and beyond
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
26 Aug 19
Atonarp will use funding for its product prototyping and commercialisation in 2020 and beyond
26 Aug 19
Philips IntelliSite Pathology Solution is designed for in-vitro diagnostic purposes
26 Aug 19
The CAN04 is currently produced in a Chinese Hamster Ovary (CHO) cell line developed by BioWa, designed using…
26 Aug 19
The study was published in the American Journal of Kidney Disease and the results of the new study…
26 Aug 19
The Sterizo Total Knee System is a technology platform based on proven design principles in the orthopedic total…
26 Aug 19
The PET/CT scans are non-invasive and painless and take approximately 30 minutes to perform
23 Aug 19
The use of this technology allows a novel way to obtain an office-based endometrial biopsy, a very common…
23 Aug 19
IDE clinical trial compares prodisc C Vivo and prodisc C SK devices with an approved TDR product as…
23 Aug 19
The suture fixation points in the Ahmed ClearPath implant are positioned more anteriorly on the device compared to…
23 Aug 19
The new manufacturing lines at NEO Tech will increase production capacity to meet the growing demand of the…